![]() ![]() The use of an SB predicted the final attachment rate during the initial surgery (P = 0.005) or at any surgery (P = 0.008. Funnel-configured RRD (P = 0.006) and the presence of grade C proliferative vitreoretinopathy (P = 0.002) correlated with re-detachment. The SSAS was 23.1% without tamponade (37.2% if including silicone oil), and final reattachment was attained in 80% (36.3% without silicone oil tamponade). Twenty-three eyes (21.5%) with RRDs were inoperable. Primary initial surgeries were vitrectomy alone (33.3%), primary scleral buckle (SB 26.9%), and vitrectomy with SB (39.7%), and 5 prophylactic SBs were placed. The average follow-up time was 3.3 ± 2.8 years, and surgical outcomes for operable eyes were restricted to patients with at least 3 months of follow-up (81 eyes). The most common systemic diagnoses were autism spectrum disorder (35.9%) and trisomy 21 (21.8%) and the most common behavior was face hitting (74.4%). Fifty-four percent of patients had bilateral RRD or phthisis bulbi in the fellow eye at final follow-up. One hundred seven eyes with RRDs were included from 78 patients. Other outcomes included new RRD in formerly attached eyes, final retinal reattachment, and final visual acuity. The rate of single-surgery anatomic success (SSAS) was the primary outcome. Patients with SIB from 23 centers with RRD in at least 1 eye.Ĭlinical histories, preoperative assessment, surgical details, postoperative management, behavioral intervention, and follow-up examination findings were reviewed. International, multicenter, retrospective, interventional case series. Electronic address: describe the clinical characteristics, surgical outcomes, and management recommendations in patients with traumatic rhegmatogenous retinal detachment (RRD) resulting from self-injurious behavior (SIB). 22 Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, Pennsylvania.Electronic address: 1 Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. Prasad Eye Institute, Hyderabad, India Department of Ophthalmology, UPMC Eye Center, University of Pittsburgh, Pittsburgh, Pennsylvania. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L. 20 Asociacion para Evitar la Ceguera en México, Mexico City, Mexico.19 Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, San Diego, California.18 Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. ![]() ![]() 17 Austin Retina Associates, University of Texas-Austin, University of Texas-San Antonio, Austin and San Antonio, Texas.16 Retina Vitreous Consultants, Monroeville, Pennsylvania.15 Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan College of Medicine, Chang Gung University, Taoyuan, Taiwan.14 Cullen Eye Institute, Baylor College of Medicine, Houston, Texas.13 Miami Ocular Oncology and Retina, Miami, Florida.12 Retina and Vitreous of Texas, Houston, Texas.11 Long Island Vitreoretinal Consultants, Great Neck, New York.10 Department of Ophthalmology, Kindai University Faculty of Medicine, Osaka, Japan.8 Department of Ophthalmology, Great Ormond Street Hospital and NIHR Biomedical Research Centre, London, United Kingdom.7 VitreoRetinal Surgery, PA, Minneapolis, Minnesota.6 The Vision Center, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, California USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, California.5 Retina Consultants, Ltd, Des Plaines, Illinois.4 Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida.3 Department of Ophthalmology, Great Ormond Street Hospital and NIHR Biomedical Research Centre, London, United Kingdom National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom Department of Ophthalmology, Royal Free Hospital, London, United Kingdom.2 Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, Los Angeles, California.1 Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |